# First in Man Study of Implantable Alginate Hydrogel

> **NCT04781660** · NA · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Implantable Alginate Hydrogel

## Key facts

- **NCT ID:** NCT04781660
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2022-02-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04781660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04781660, "First in Man Study of Implantable Alginate Hydrogel". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04781660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
